Viewing Study NCT00503204

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:55 PM

Ignite Modification Date: 2025-12-27 @ 1:31 AM

Study NCT ID: NCT00503204

Status: COMPLETED

Last Update Posted: 2009-11-25

First Post: 2007-07-16

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Sponsor: AstraZeneca

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module